Aptamers in Ocular Disease Therapy and Drug Delivery: Current Progress and Future Opportunities

Sandra Carolina Durán-Cristiano, Juan David Ospina-Villa, Marlies Gijs · 2026

Read Aptamers in Ocular Disease Therapy and Drug Delivery: Current Progress and Future Opportunities by Sandra Carolina Durán-Cristiano, Juan David Ospina-Villa, Marlies Gijs (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13316312.txt.

Description

Sandra Carolina Durán-Cristiano, Juan David Ospina-Villa, and Marlies Gijs review aptamers as tools for eye medicine, in a 2026 paper. Aptamers are short strands of DNA or RNA that fold to grip one chosen target. Their tight, selective grip suits precision treatment and targeted drug delivery. In eye care, aptamer platforms have grown up around retinal disease, glaucoma, and disorders of the eye's surface.

Searching five databases, the team gathered twenty-four aptamer platforms that reached lab, animal, clinical, or approved stages. In age-related macular degeneration, most aptamers aim at growth and blood-vessel signals and serve as treatments in their own right. In glaucoma they lean toward protecting nerve cells, limiting scarring, and easing fluid drainage. The review maps each platform's target and stage, and weighs what aptamers still must prove before eye doctors can use them widely.

Catalog record

CREATORSandra Carolina Durán-Cristiano, Juan David Ospina-Villa, Marlies Gijs
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13316312

Browse the full library · About the Tower of Babel